Partial splenic embolization combined with endoscopic therapies and NSBB decreases the variceal rebleeding rate in cirrhosis patients with hypersplenism: a multicenter randomized controlled trial

ConclusionsThe EP treatment was more effective in preventing variceal rebleeding and variceal recurrence than the conventional E treatment during the secondary prophylaxis of VH in cirrhosis patients with hypersplenism. Furthermore, the EP treatment could significantly increase the peripheral blood cell count and albumin concentration and also improved the coagulation function and the Child –Pugh score.Clinical trials registrationTrial registration number ClincialTrials.gov: NCT02778425. The URL of the clinical trial:https://clinicaltrials.gov/
Source: Hepatology International - Category: Infectious Diseases Source Type: research